scholarly journals Cardioprotective medication adherence among patients with coronary heart disease in China: a systematic review

Heart Asia ◽  
2019 ◽  
Vol 11 (2) ◽  
pp. e011173 ◽  
Author(s):  
Zhao Ni ◽  
Latefa Dardas ◽  
Bei Wu ◽  
Ryan Shaw

In China, poor cardioprotective medication adherence is a key reason for the high mortality rate of coronary heart disease (CHD). The aims of this systematic review are to (1) describe and synthesise factors that influence medication adherence among Chinese people with CHD, (2) evaluate the current status of intervention studies, and (3) discuss directions of future research to improve medication adherence. A comprehensive search using PubMed, Cumulative Index to Nursing and Allied Health Literature, Embase, Scopus, Global Health and PsycINFO was undertaken to describe poor adherence in China. Thirty-three eligible articles were included in the study. The review shows that there are multiple contributing factors to poor medication adherence, including patients’ sociodemographic characteristics, health status and medication characteristics. In addition, from patients’ perspective, lack of medication-related knowledge, such as the name, function, dosage and frequency, contributes to poor adherence. From physicians’ perspective, a gap exists between CHD secondary prevention guidelines and clinical practice in China. Follow-up phone calls, educational lectures, booklets and reminder cards were common methods found to be effective in improving medication adherence. This systematic review indicates that cardioprotective medications were commonly prescribed as secondary prevention medication to patients with CHD in China, but adherence to these medications gradually decreased during a follow-up period. Therefore, more research should be conducted on how to establish high-quality health educational programmes aimed at increasing patients’ medication adherence.

2021 ◽  
Vol 57 ◽  
pp. 102643
Author(s):  
Jingen Li ◽  
Xiang Gao ◽  
Xuezeng Hao ◽  
Dimitrios Kantas ◽  
Essa A. Mohamed ◽  
...  

1994 ◽  
Vol 55 (10) ◽  
pp. 1201-1210 ◽  
Author(s):  
Cesare Alessandri ◽  
Stefania Basili ◽  
Massimo Leonardo ◽  
Giovanni Pettirossi ◽  
Michele Paradiso ◽  
...  

2017 ◽  
Vol 25 (3) ◽  
pp. 247-259 ◽  
Author(s):  
Suzanne H Richards ◽  
Lindsey Anderson ◽  
Caroline E Jenkinson ◽  
Ben Whalley ◽  
Karen Rees ◽  
...  

Background Although psychological interventions are recommended for the management of coronary heart disease (CHD), there remains considerable uncertainty regarding their effectiveness. Design Systematic review and meta-analysis of randomised controlled trials (RCTs) of psychological interventions for CHD. Methods The Cochrane Central Register of Controlled Trials, MEDLINE, EMBASE, CINAHL and PsycINFO were searched to April 2016. Retrieved papers, systematic reviews and trial registries were hand-searched. We included RCTs with at least 6 months of follow-up, comparing the direct effects of psychological interventions to usual care for patients following myocardial infarction or revascularisation or with a diagnosis of angina pectoris or CHD defined by angiography. Two authors screened titles for inclusion, extracted data and assessed risk of bias. Studies were pooled using random effects meta-analysis and meta-regression was used to explore study-level predictors. Results Thirty-five studies with 10,703 participants (median follow-up 12 months) were included. Psychological interventions led to a reduction in cardiovascular mortality (rfcelative risk 0.79, 95% confidence interval [CI] 0.63 to 0.98), although no effects were observed for total mortality, myocardial infarction or revascularisation. Psychological interventions improved depressive symptoms (standardised mean difference [SMD] –0.27, 95% CI –0.39 to –0.15), anxiety (SMD –0.24, 95% CI –0.38 to –0.09) and stress (SMD –0.56, 95% CI –0.88 to –0.24) compared with controls. Conclusions We found that psychological intervention improved psychological symptoms and reduced cardiac mortality for people with CHD. However, there remains considerable uncertainty regarding the magnitude of these effects and the specific techniques most likely to benefit people with different presentations of CHD.


2018 ◽  
Vol 10 (6) ◽  
pp. 62
Author(s):  
Sulaiman Al Mashrafi ◽  
Hilal Al Shamsi ◽  
Abdullah Ghthaith Almutairi

BACKGROUND: Coronary heart disease (CHD) is a leading cause of death worldwide. Saturated fats were known as a risk factor for CHD and dietary guidelines restrict the daily consumption of SFs. However, the association between SFs and higher risk of CHD is not clear. This systematic review includes 14 high-quality prospective cohort studies which reported the association between CHD and SFs.  OBJECTIVE: This systematic review aims to examine the association between SFs intake and higher risk of CHD among prospective cohort studies.DESIGN: A systematic review was conducted for published literaure in Scopus and ProQuest during the period 2000 to 2017. Studies included if they have a prospective cohort design with follow-up more than 4 years, published in English, and provide information about the association of interest. Data were extracted and summarised into three tables.RESULTS: A total number of 14 prospective cohort studies were included in this review in which all from developed countries and half of them were from the USA. The total number of participants ranging from 501 to 344,696 in follow-up period from 4.8 to 30 years where 26,322 events of CHD and 629 CHD deaths were reported. The highest positive association HR (95%CI) was 5.17 (1.64-16.36) for CHD mortality and 1.36 (0.98-1.88) for CHD incidence. In contrast, the highest inverse association was found 0.73 (0.53-1.01) for CHD mortality and 0.62 (0.35-1.11) for CHD incidence. CONCLUSION: This systematic review suggests that SFs intake was not associated with higher incidence or mortality of CHD.


Sign in / Sign up

Export Citation Format

Share Document